PDCD1 and neoplasm: This approach was exemplified by a recent study predicting tumour responses to PD-1 blockade using blood-based immune profiling combined with tumour imaging.110 A period of consolidated effort to sample blood and liver in parallel is therefore essential to delineate peripheral markers that adequately reflect intrahepatic events in CHB.